Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Dec;30(6):591-6.
doi: 10.1111/j.1365-2710.2005.00689.x.

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea

T Fukuda  1 , E Yukawa, G Kondo, T Maeda, T Shin-o, Y Kondo, T Imamura, M Irikura, Tetsumi Irie
Affiliations

Population pharmacokinetics of theophylline in very premature Japanese infants with apnoea

T Fukuda et al. J Clin Pharm Ther. 2005 Dec.

Abstract

Objective: To estimate the population pharmacokinetics of theophylline in very premature infants using the non-linear mixed effects modelling.

Method: A total of 167 serum concentration measurements obtained from routine theophylline monitoring of 107 very premature Japanese infants were collected.

Results: The final pharmacokinetic parameters were CL (mL/h) = [6.98 . body weight (BW) (kg)(2.17) + 0.244 . post-conceptional age (weeks)] . 1.24(oxygen support), Vd (L) = 0.492 . BW (kg) and F = 0.660, respectively. Clearance was increased by 24% for patients receiving oxygen support. The inter-individual variabilities in clearance and apparent volume of distribution were 15.6% and 80.4%, respectively, and the residual variability was 34.2% as a coefficient of variation.

Conclusion: Application of the findings in this study to patient care may permit selection of an appropriate initial maintenance dosage to achieve target theophylline concentrations, thus enabling the clinician to achieve the desired therapeutic effect in very premature Japanese infants.

PubMed Disclaimer

LinkOut - more resources